canadian semaglutide Health Canada has approved the first generic injection for weight loss in Canada. The medication, called Svemia, is made by company Apotex and is the first generic version of Wegovy Sandoz Eyes End-of-June Canadian Launch

the expected effect size is small and the onset is slow - Avoid antidepressants in bipolar depression presenting with subtle increased psychomotor tempo, pressured speech and racing thoughts due to the increased risk of switch and potentially rapid cycling - Consider ETC as a viable option for the treatment of bipolar depression resistant to pharmacological treatment - Never treat with antidepressants without a mood stabiliser - If an antidepressant is added, use mainly SSRIs due to their low switch rate - If an antidepressant is used in maintenance treatment, the occurrence of manic/mixed symptoms should be monitored carefully The above recommendation is consistent with current Danish guidelines for the pharmacological treatment of bipolar disorder [42], which recommend lithium, quetiapine and lamotrigine as first-line agents for bipolar I disorder, current depressive episode, in at least 70% of patients, and for bipolar II disorder, current depressive episode, in at least 60%

Optimize oral hygiene Bacteria are present everywhere in your mouth, such as the tongue, teeth, and gums, which may cause bad breath and affect your oral hygiene

We identified a T2DM cohort of 294,148 participants from the Korean NHIS database from 2009 to 2018 (Fig

Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research

Both compounded semaglutide and Ozempic work by activating GLP-1 receptors to reduce appetite and improve blood sugar control, yet they originate from fundamentally different manufacturing pathways

No formal contraindications derive from human data